Muris Kobaslija

Senior Director, CMC/Manufacturing Technical Services at Alnylam Pharmaceuticals - Cambridge, Massachusetts, US

Muris Kobaslija's Colleagues at Alnylam Pharmaceuticals
Azadeh Sichani

Principal Associate Scientist

Contact Azadeh Sichani

Mabelle Abreu-Sanchez

Senior Manager, Talent Acquisition

Contact Mabelle Abreu-Sanchez

Maryam Sangari

MEDICAL SCIENCE LIAISON (MSL)

Contact Maryam Sangari

Jainan Naik

Associate Director of Finance

Contact Jainan Naik

Megan Melch

Senior Manger, Clinical Pharmacology and Pharmacometrics

Contact Megan Melch

Jeannine Ripley

Director Talent Acquisition

Contact Jeannine Ripley

Shuichi Nakagawa

Senior Manager Facilities Operation Japan Asia

Contact Shuichi Nakagawa

View All Muris Kobaslija's Colleagues
Muris Kobaslija's Contact Details
HQ
(617) 551-8200
Location
Devens,Massachusetts,United States
Company
Alnylam Pharmaceuticals
Muris Kobaslija's Company Details
Alnylam Pharmaceuticals logo, Alnylam Pharmaceuticals contact details

Alnylam Pharmaceuticals

Cambridge, Massachusetts, US • 2460 Employees
SaaS

ALNYLAM IS LEADING THE RNAi REVOLUTION™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-23), Science Magazine (2018-23), Fast Company (Best Workplaces for Innovators 2020-23) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Rna Therapeutics Innovative Treatments Ocular Disease Treatment
Details about Alnylam Pharmaceuticals
Frequently Asked Questions about Muris Kobaslija
Muris Kobaslija currently works for Alnylam Pharmaceuticals.
Muris Kobaslija's role at Alnylam Pharmaceuticals is Senior Director, CMC/Manufacturing Technical Services.
Muris Kobaslija's email address is ***@alnylam.com. To view Muris Kobaslija's full email address, please signup to ConnectPlex.
Muris Kobaslija works in the SaaS industry.
Muris Kobaslija's colleagues at Alnylam Pharmaceuticals are Azadeh Sichani, Mabelle Abreu-Sanchez, Maryam Sangari, Jainan Naik, Megan Melch, Jeannine Ripley, Shuichi Nakagawa and others.
Muris Kobaslija's phone number is (617) 551-8200
See more information about Muris Kobaslija